Monthly Archives: October 2014

Here is an example of a ‘preventable’ medication error resulting in the tragic death of 15 children and reported in the recent Lancet Global Health. Copied as fair use. The chaotic condition in Syria may have contributed to this tragedy. … Continue reading →

MSF responds to second Wikileaks release of Trans-Pacific Partnership text 16 October, 2014 https://www.msfaccess.org/content/msf-responds-second-wikileaks-release-trans-pacific-partnership-text Today [Oct16, 2014] Wikileaks published a revised copy of the intellectual property  chapter from the secret Trans-Pacific Partnership (TPP) negotiations:  https://wikileaks.org/tpp-ip2/ The leaked document — dated … Continue reading →

Dr Mira Shiva The Drug Information Association of India Conference is currently being held in Mumbai. The theme is Future of Health Care in India: Patients, Innovation & Access . I am chairing the session on Status of Patient Advocacy … Continue reading →

2014 Newton et al. Open access article published under the terms of CCBY. Published by Elsevier Ltd. http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70279-7/fulltext#aff2 The Lancet Global Health, Volume 2, Issue 9 , Pages e509 – e510, September 2014 doi:10.1016/S2214-109X(14)70279-7 Poor-quality medicines and medical products, both substandard … Continue reading →

(Published 22 September 2014) Cite this as: BMJ 2014;349:g5799 Jane Parry GlaxoSmithKline’s China operation has been fined $488 million after being found guilty of bribery by the Changsha Intermediate People’s Court in Hunan province. In the closed door trial, which … Continue reading →